Our GLP1R fluorescent ligands have been tested extensively in a range of cell lines and have been found to be highly specific for the GLP-1 receptor. They are ideal for studying the GLP1 receptor in various contexts, including the study of type 2 diabetes, weight loss, and kidney disease. As a market leader in fluorescent ligand development, we are uniquely positioned to supply high-quality GLP1R solutions with high affinity for the GLP-1 receptor, making them ideal for various applications, including live cell imaging, receptor activation assays, and more.
LUXendins have been developed by Johannes Broichhagen (Max Planck Institute for Medical Research, Heidelberg, Germany and Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany) and David J. Hodson (University of Birmingham), and are exclusively licensed to Celtarys for commercialization. These ligands have been shown to be highly effective in studying the GLP-1 receptor and related proteins, including glucagon-like peptide and GLP-1 receptor agonists. The ligands are also highly effective in studying the nervous system, blood sugar levels, and cell surface signaling pathways. They have been shown to be highly effective in binding to the receptor, activating it, and studying its downstream effects.
At Celtarys, we are committed to providing you with the best products on the market for studying G protein-coupled receptors, and we are constantly developing new solutions to meet your needs.
3 nmol vial that allows to prepare 30 µL of 100 µM stock solution to test GLP1R. One vial is sufficient for injecting one mouse. Please note that the required concentration may vary depending on the specific assay design. Price: 424,00€.
Esta entidad fue beneficiaria de las ayudas para la ejecución de acciones de promoción exterior de las empresas gallegas. El objetivo principal de estas ayudas es incentivar la realización de acciones de promoción exterior generadoras de ventajas competitivas. El resultado que se pretende conseguir es el impulso de las pymes y sus productos y servicios, aumentando el número de empresas de base exportadora.
Celtarys Research is beneficiary of a WomenTechEU grant supporting deep-tech start-ups led by women.
Principia 2021 Program: Celtarys staff has been funded by the Xunta de Galicia within the framework of the PRINCIPIA 2021 Program of the Galician Innovation Agency (GAIN).
InnovaPEME Program: Celtarys Innovation Plan has been funded by the InnovaPEME 2022 program of the Galician Innovation Agency (GAIN).
Bonos de Innovación de Celtarys Research (026): Para promover o desenvolvemento tecnolóxico, a innovación e unha investigación de calidade. Esta operación está financiada pola Xunta de Galicia, a través de axudas concedidas pola Axencia Galega de Innovación, dentro do programa de axudas a empresa Bonos de innovación 2022.
